Emami to Acquire Remaining Stake in Axiom Ayurveda for INR 200 Cr
The Kolkata-based FMCG company previously held about 26.5% in Axiom.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Emami Limited has signed a definitive agreement to acquire the remaining 73.5% stake in Axiom Ayurveda Pvt Ltd for a total consideration of up to INR 200 crore, according to a disclosure filed with the National Stock Exchange.
The Kolkata-based FMCG company previously held about 26.5% in Axiom.
In the first tranche of the deal, Emami has acquired an additional 36.7% stake, taking its total shareholding to over 63%. The remaining stake will be acquired in phases over the next three months, subject to regulatory approvals and customary closing conditions.
Founded in 1995, Axiom Ayurveda operates in the health and wellness segment with brands such as AloFrut, Jeevan Ras, and Mukti Gold. Its flagship product, AloFrut, an aloe vera pulp-based fruit beverage, has established a presence across general trade and institutional channels.
Axiom reported a turnover of around INR 107 crore in FY25 and is expected to grow to approximately INR 180 crore in FY26. The projected growth is likely to be supported by Emami’s distribution network and brand-building capabilities.
The acquisition reflects a broader trend among FMCG companies diversifying beyond core personal care portfolios into food and beverage categories. Several firms have recently invested in ayurveda and natural product businesses, including Dabur, Reliance Retail, and Estée Lauder.
Following the acquisition, Axiom will be led by Harkirat Bedi as chief executive officer. The move comes as India’s ayurveda and natural products market, estimated at USD 10–12 billion, continues to grow faster than traditional FMCG segments.
Emami Limited has signed a definitive agreement to acquire the remaining 73.5% stake in Axiom Ayurveda Pvt Ltd for a total consideration of up to INR 200 crore, according to a disclosure filed with the National Stock Exchange.
The Kolkata-based FMCG company previously held about 26.5% in Axiom.
In the first tranche of the deal, Emami has acquired an additional 36.7% stake, taking its total shareholding to over 63%. The remaining stake will be acquired in phases over the next three months, subject to regulatory approvals and customary closing conditions.
Founded in 1995, Axiom Ayurveda operates in the health and wellness segment with brands such as AloFrut, Jeevan Ras, and Mukti Gold. Its flagship product, AloFrut, an aloe vera pulp-based fruit beverage, has established a presence across general trade and institutional channels.
Axiom reported a turnover of around INR 107 crore in FY25 and is expected to grow to approximately INR 180 crore in FY26. The projected growth is likely to be supported by Emami’s distribution network and brand-building capabilities.
The acquisition reflects a broader trend among FMCG companies diversifying beyond core personal care portfolios into food and beverage categories. Several firms have recently invested in ayurveda and natural product businesses, including Dabur, Reliance Retail, and Estée Lauder.
Following the acquisition, Axiom will be led by Harkirat Bedi as chief executive officer. The move comes as India’s ayurveda and natural products market, estimated at USD 10–12 billion, continues to grow faster than traditional FMCG segments.
